366 results
High-quality randomized trials evaluating tocilizumab continue to show only modest effects in patients with severe COVID-19. Read about the latest trial in this EBM Focus article.
SARS-CoV-2 is mutating, as viruses do. Read about notable SARS-CoV-2 variants and their clinical impact from the Infectious Diseases team at DynaMed®.
Colonoscopy is the gold standard for colorectal cancer screening, but a variety of newer tests have been developed. Here the EBM Focus team discusses the options.
While COVID-19 took much of the world’s attention in 2020, clinical research in other areas continued. Here are the top DynaMed® topics and important new research in those areas.
A new study suggests lower blood pressure goals may be appropriate for cardiovascular risk reduction in women compared to men, but does data really support it?
What global health issues should we keep an eye on in 2021? Dr. Stephen A. Berger co-founder of GIDEON (Global Infectious Diseases and Epidemiology Network) outlines five candidates that may re-emerge post-pandemic.
All patients with type 1 diabetes require life-long insulin due to absent or near-absent beta-cell function. Insulin therapy in patients with type 1 diabetes should ideally be managed with an endocrinologist.
Read about a new study supporting use of direct oral anticoagulants (DOACs) for patients with valvular atrial fibrillation, including its limitations, in this EBM Focus article.
Insulin therapy is often required in the treatment of diabetes but there is much to consider when prescribing it, starting with which condition is prompting the need.
Patients are reporting lingering symptoms after acute COVID-19. Read about post-acute COVID-19 syndrome (PACS) also known as long COVID.